Investor Relations Captor Therapeutics ®
Notice of reduction of shareholding interest in Company
Publication date:
Publication time:
Current report no. 22/2021
Date of preparation: 2 July 2021
Subject: Notice of reduction of shareholding interest in Company
Legal basis: Article 70 point 1) of the Act on Public Offering and Conditions Governing the Introduction of Financial Instruments to Organized Trading System and of Public Companies dated 29 July 2005
The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”) informs that it received from Filip Jeleń a notice of reduction of his shareholding to 3.40% of the total number of votes in the Company, drawn up pursuant to Article 69 sec. 1 point 2) of the Act on Public Offering and Conditions Governing the Introduction of Financial Instruments to Organized Trading System and of Public Companies dated 29 July 2005.
The notice constitutes an appendix to this report.